IBRX - ImmunityBio Inc
2.07
-0.020 -0.966%
Share volume: 6,528,774
Last Updated: 05-09-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$2.09
-0.02
-0.01%
View ratios
Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
Report Date | 05-11-2023 | 08-08-2023 | 11-09-2023 | 03-19-2024 | 05-09-2024 | 08-12-2024 | 11-12-2024 | 03-03-2025 | |
Cash flow financing | 76.888 M | 43.412 M | 237.502 M | 200.539 M | 10.225 M | 148.894 M | 15.582 M | 106.929 M | |
Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 10.225 M | 48.313 M | 15.582 M | -803.000 K | |
Cash flow | -84.310 M | -79.773 M | -87.403 M | -115.271 M | -132.379 M | -2.943 M | -18.149 M | 31.619 M | |
Net income | -116.343 M | -137.879 M | -95.582 M | -233.392 M | -134.130 M | -134.584 M | -85.752 M | -59.179 M | |
Depreciation | 4.681 M | 4.682 M | 4.585 M | 4.564 M | 4.555 M | 4.406 M | 4.455 M | 4.138 M | |
Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Changes in receivables | 1.464 M | 2.025 M | 2.325 M | 2.019 M | 0.000 | 0.000 | 0.000 | 0.000 | |
Investing Cashflow | -8.484 M | -8.604 M | -15.631 M | 2.249 M | -35.622 M | -51.490 M | 65.032 M | 9.834 M | |
Net Borrowings | 654.229 M | 754.356 M | 504.509 M | 330.072 M | 0.000 | 0.000 | 0.000 | 0.000 | |
Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Capital Expenditures | -8.428 M | -8.526 M | -5.675 M | -7.955 M | 1.261 M | 724.000 K | 2.792 M | 2.111 M | |
Cash Change | 91.268 M | 45.954 M | 189.796 M | 266.462 M | -132.379 M | -2.970 M | -18.122 M | 31.619 M |